Trailing-twelve-month (TTM) revenue is $5.91 Billion with a year-over-year growth of +18.32%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,307,829,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $1,428,031,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $1,428,731,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $1,743,313,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $5,907,904,000 |
Current P/S: $12,798,268,327 market capitalization ÷ $5,907,904,000 TTM revenue = 2.17x.
Market capitalization source: FMP quote. Quote observed 2026-09-24T13:50:10.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.74B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-24T13:50:23.451Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Bromine | N/A | N/A | N/A | $1.4B | N/A | N/A |
| Bromine Specialties | $1.0B | $965M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Foreign | $2.7B | $2.4B | $2.6B | $6.4B | $4.5B | N/A |
| UNITED STATES | $858M | $744M | $731M | $889M |
$5.91B
$5.91 Billion
+18.32%
vs. $4.99B a year ago (TTM)
+12.84%
5 Year compound annual growth rate
1 Year
+18.32%
3 Year
(15.12%)
5 Year
+12.84%
10 Year
+7.19%
15 Year
+5.55%
20 Year
+4.90%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $5.14B | ($234.79M) | (4.37%) |
| 2024 | $5.38B | ($4.24B) | (44.08%) |
| 2023 | $9.62B | +$2.30B | +31.38% |
| 2022 | $7.32B | +$3.99B | +119.96% |
| 2021 | $3.33B | +$199.05M | +6.36% |
| 2020 |
TTM Growth
+18.32%
3-Year CAGR
(15.12%)
5-Year CAGR
+12.84%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-24T13:50:23.451Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| Catalysts | $1.1B | $798M | $761M | $900M | N/A | N/A |
|---|
| Energy Storage | N/A | N/A | N/A | N/A | $3.0B | $2.7B |
|---|
| Ketjen | N/A | N/A | N/A | N/A | $1.0B | $1.1B |
|---|
| Lithium | $1.4B | $1.1B | $1.4B | $5.0B | N/A | N/A |
|---|
| Specialties | N/A | N/A | N/A | N/A | $1.3B | $1.4B |
|---|
| $902M |
| $890M |
| $3.13B |
| ($460.52M) |
| (12.83%) |
| 2019 | $3.59B | +$214.48M | +6.35% |
| 2018 | $3.37B | +$302.97M | +9.86% |
| 2017 | $3.07B | +$394.77M | +14.75% |
| 2016 | $2.68B | ($149.23M) | (5.28%) |
